Arkema welcomes the European Commissions initiative to introduce the Industrial Accelerator Act (IAA). Having signed the Call for European Preference issued by Executive Vice-President Stéphane Séjourné in February 2026, we see this proposal as a decisive step toward strengthening Europes industrial resilience and especially the chemical industry via targeted European preference and support to sustainable value…
ARK
Arkema
Company · France · EU Transparency Register 35321797057-83
3
positions filed
in the 326 files tracked
3
legislative files
of 326 tracked
3
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 925 companies & groups on this site, they rank #258 by legislative files engaged — a count of participation, not a measure of influence.
2.2
declared lobbying FTE
self-declared
€200K+
declared costs / yr (floor)
1
EP accreditations
as declared to the register
2011
in the register since
Declares membership of
- National : France Chimie
- AFEP
- France Industrie →
- UNIDEN. →
- EU : CEFIC (including some Sector Groups)
- Plastics Europe (including some Sector Groups)
- RECHARGE
- EPEE (European partnership for energy and the environment)
- E-Pure
- BIC.
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Companies & groups
- Registered as
- ARKEMA
- Head office
- Paris La Défense Cedex, France
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Arkema in PolicySpeak: request access →
Work at Arkema? so we know who speaks for it.
Their record over time
Arkema filed 3 positions between 5 Jun 2026 and 18 Jun 2026, across 3 of the 326 legislative files tracked here, attaching a full position paper 3 times.
What they argued
Arkema underlines the significant methodological issues of comparability and replicability for the setting of the fallback "heat" benchmark, leading to a maximum reduction of -50% compared to the initial benchmark value of phase III and -34% compared to to the benchmark value of phase IV.1.
Arkema supports the Biotech Act II as a mean to support a clear and strong commitment from the EU to support its bio-based materials and chemicals industrial base, both for mature and developing productions. This is essential to support decarbonisation, strategic autonomy and defossilisation. Please find attached our complete submission.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
- IDEE ECONOMICHE www.idee-economiche.it · 3 files in common
- Cefic · 3 files in common
- Danish Industry · 3 files in common
- BASF SE · 3 files in common
- FuelsEurope · 3 files in common
Showing 5 of 91.
Is this your organization?
Everything on this page comes from Arkema’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.